4
Changes in Ownership
Harmony Biosciences Holdings, Inc. Filed Acc 0001104659-22-002722
Chief Commercial Officer sold 6,125 shares at an average $40.37 ($247,258)
- Chief Commercial Officer acquired 6,125 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Dierks Jeffrey · Chief Commercial Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-01-06 | Exercise or conversion : show line 1 in the form | +6,125 | $8.22 | $50,348 | 6,125 | D |
| 2022-01-06 | Sale : show line 2 in the form | −1,399 | $39.60 | $55,396 | 4,726 | D |
| 2022-01-06 | Sale : show line 3 in the form | −4,302 | $40.53 | $174,379 | 424 | D |
| 2022-01-06 | Sale : show line 4 in the form | −424 | $41.23 | $17,482 | 0 | D |
| Open-market sales · 6,125 sh · avg $40.37 · $247,258 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-01-06 | Exercise or conversion : show line 5 in the form Stock Option | −3,690 | 9,739 | D |
| 2022-01-06 | Exercise or conversion : show line 6 in the form Stock Option | −2,435 | 4,869 | D |
Loading xslF345X03/tm221863-2_4seq1.xml…